Ely Benaim serves as Executive at REXAHN PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Ely Benaim has executed 47 insider transactions totaling $5.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 6, 2023 involved receiving (via award) 98 shares valued at $6.1K.
Ely Benaim currently holds 28,770 shares of REXAHN PHARMACEUTICALS, INC. (RNN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ely Benaim has been a net seller of RNN stock. They have purchased $0 and sold $5.7M worth of shares.
Ely Benaim's most recent insider trade was on Jan 6, 2023, when they sold 98 shares at $62.31 per share.
Get notified when new Form 4 filings are submitted
| $74.00 |
| Discretionary |
| Aug 3, 2022 | NVCR | $40.0K | Sale | 563 | $71.09 | Discretionary |
| Aug 2, 2022 | NVCR | $30.4K | Sale | 437 | $69.66 | Discretionary |
| Jul 5, 2022 | NVCR | $13.1K | Award | 222 | $59.08 | Discretionary |
| May 11, 2022 | NVCR | $130.8K | Sale | 2,135 | $61.25 | Discretionary |
| May 10, 2022 | NVCR | $134.9K | Sale | 2,070 | $65.16 | Discretionary |
| Mar 4, 2022 | NVCR | $106.3K | Sale | 1,510 | $70.41 | Discretionary |
| Mar 3, 2022 | NVCR | $0 | Award | 17,371 | $N/A | Discretionary |
| Mar 3, 2022 | NVCR | $59.8K | Sale | 803 | $74.50 | Discretionary |
| Jan 6, 2022 | NVCR | $3.5K | Award | 55 | $63.82 | Discretionary |
| Aug 3, 2021 | NVCR | $69.7K | Sale | 464 | $150.11 | Discretionary |
| Aug 2, 2021 | NVCR | $80.1K | Sale | 536 | $149.38 | Discretionary |
| Jul 30, 2021 | NVCR | $103.5K | Sale | 651 | $158.96 | Discretionary |
| Jul 30, 2021 | NVCR | $54.2K | Option Exercise | 651 | $83.30 | Discretionary |
| Jul 6, 2021 | NVCR | $12.3K | Award | 90 | $137.12 | Discretionary |
| May 27, 2021 | NVCR | $366.6K | Sale | 1,833 | $200.00 | Discretionary |
| May 27, 2021 | NVCR | $87.2K | Option Exercise | 1,833 | $47.56 | Discretionary |
| May 12, 2021 | NVCR | $350.7K | Sale | 1,943 | $180.48 | Discretionary |
| May 11, 2021 | NVCR | $407.4K | Sale | 2,262 | $180.12 | Discretionary |
| May 10, 2021 | NVCR | $87.2K | Option Exercise | 1,833 | $47.56 | Discretionary |
| May 10, 2021 | NVCR | $347.6K | Sale | 1,833 | $189.65 | Discretionary |
| Apr 13, 2021 | NVCR | $130.2K | Sale | 651 | $200.00 | Discretionary |
| Apr 13, 2021 | NVCR | $241.0K | Option Exercise | 3,474 | $69.37 | Discretionary |
| Apr 13, 2021 | NVCR | $87.2K | Option Exercise | 1,833 | $47.56 | Discretionary |
| Apr 13, 2021 | NVCR | $54.2K | Option Exercise | 651 | $83.30 | Discretionary |
| Apr 13, 2021 | NVCR | $366.6K | Sale | 1,833 | $200.00 | Discretionary |
| Apr 13, 2021 | NVCR | $694.8K | Sale | 3,474 | $200.00 | Discretionary |
| Mar 5, 2021 | NVCR | $383.8K | Sale | 2,918 | $131.53 | Discretionary |
| Mar 4, 2021 | NVCR | $259.7K | Sale | 1,888 | $137.55 | Discretionary |